Basics MIRUM PHARMACEUTICALS, INC. IPO Date: July 12, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.52B Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 2.52% Avg Daily Range (30 D): $1.10 | 1.56% Avg Daily Range (90 D): $1.19 | 1.72% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .41M Avg Daily Volume (90 D): .55M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 1,829 Avg Inst. Trade: $2.55M Avg Inst. Trade (30 D): $6.04M Avg Inst. Trade (90 D): $5.61M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.98M Avg Closing Trade (30 D): $5.85M Avg Closing Trade (90 D): $6.95M Avg Closing Volume: 81.34K     News Dec 3, 2025 @ 11:30 AM Prediction: This Stock Has Soared Nearly 70% in 20... Source: Keith Speights Jun 18, 2024 @ 3:14 PM Mirum (MIRM) Soars on Interim Data From Liver Dise... Source: Zacks Equity Research Jun 18, 2024 @ 9:46 AM Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Furth... Source: Zacks Equity Research Jun 7, 2024 @ 3:30 PM Why Is Mirum Pharmaceuticals (MIRM) Down 3.4% Sinc... Source: Zacks Equity Research May 28, 2024 @ 2:02 PM Mirum's (MIRM) Livmarli Aids Sales but Overdepende... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.84 $.06 $-.12 Diluted EPS $-.84 $.05 $-.12 Revenue $ 471.79M $ 133.01M $ 127.79M Gross Profit $ $ $ Net Income / Loss $ -41.42M $ 2.91M $ -5.86M Operating Income / Loss $ -41.79M $ 2.6M $ -4.99M Cost of Revenue $ $ $ Net Cash Flow $ 56.86M $ 53.55M $ 14.13M PE Ratio